PRIMO MEDICO Fachärzte Talk: Podcasts aus Gesundheit & Medizin

Lung cancer remains one of the most common forms of malignant tumors in Germany. Lung neoplasms often develop without causing noticeable symptoms in its early stages. This makes risk-based screening particularly important for people with a long history of smoking or relevant occupational exposure.

In this episode of the PRIMO MEDICO Specialist Talk, Prof. Dr. Peter Kleine explains how modern lung cancer screening works and why low-dose computed tomography plays a central role in detecting suspicious changes at an early stage. The Clinic Director and Chief of Thoracic Surgery at Sana Klinikum Offenbach discusses how artificial intelligence and interdisciplinary diagnostics can support radiologists in identifying even very small pulmonary nodules. Professor Kleine specialises in minimally invasive and complex thoracic surgical procedures, working closely with experts from pulmonology, oncology, radiology, pathology and radiation therapy at the hospital’s Lung Cancer Centre.

The conversation follows the patient journey from the first suspicious finding and tissue sampling to interdisciplinary treatment planning. Prof. Kleine presents modern surgical options, including video-assisted thoracic surgery, or VATS, robotic-assisted procedures and complex lung-preserving operations such as sleeve resections. He explores immunotherapy, targeted medication for specific genetic mutations and the importance of regular follow-up examinations. Finally, Prof. Kleine offers an insight into current research investigating whether tumour DNA in the blood could one day help detect cancer recurrence earlier and reduce the need for repeated CT scans.

• Lung cancer incidence and changing trends among women and men

This podcast episode in English was produced using AI-powered translation and dubbing technology (ElevenLabs Dubbing) based on the original recording. The content corresponds to the original interview. The AI voice has been used with the consent of the interviewee. No additional personal data has been processed.

Rückenschmerzen sind weit verbreitet und in den meisten Fällen harmlos. Doch wann können die Beschwerden auf einen Tumor an der Wirbelsäule oder im Rückenmark hinweisen? Welche Schmerzen sollten Betroffene ernst nehmen – und welche modernen Behandlungsmöglichkeiten stehen heutzutage zur Verfügung?

In dieser Folge des PRIMO MEDICO Fachärzte-Talks spricht Prof. Dr. med. (habil.) Eleftherios Archavlis, FACS, Chefarzt des Interdisziplinären Wirbelsäulenzentrums Frankfurt und Spezialist für Wirbelsäulenchirurgie im Facharztzentrum MEDICI Frankfurt, über die unterschiedlichen Arten von Wirbelsäulen- und Rückenmarkstumoren. Er erklärt, warum ein Tumor nicht automatisch bösartig sein muss und welche Bedeutung eine frühzeitige, präzise Diagnostik hat.

Im Mittelpunkt stehen mögliche Warnzeichen wie nächtliche oder zunehmende Rückenschmerzen, Taubheitsgefühle, Muskelschwäche, Gangunsicherheit sowie Störungen der Blasen- oder Darmfunktion. Prof. Archavlis erläutert außerdem, wann eine Wirbelsäulenoperation notwendig wird und welche Rolle mikrochirurgische und minimalinvasive Verfahren, Neuromonitoring, Navigation, Strahlentherapie und medikamentöse Tumortherapien spielen. Mithilfe interdisziplinär und individuell abgestimmter Therapiekonzepte wird zum Ziel gesetzt, Tumore bestmöglich zu kontrollieren, neurologische Funktionen und die Stabilität der Wirbelsäule zu erhalten sowie Schmerzen zu lindern und die Lebensqualität zu verbessern.

Diese Podcast-Folge wurde mithilfe von KI-gestützten Audiotechnologien produziert. Die gesprochenen Inhalte werden vollständig durch KI-generierte Stimmen wiedergegeben. Auch eine KI-basierte Rekonstruktion der Stimme des interviewten Arztes kann angewandt sein. Die Verwendung der Stimmen erfolgt mit Zustimmung der beteiligten Gesprächspartner. Die medizinischen Inhalte wurden vor Veröffentlichung vom interviewten Arzt geprüft und freigegeben. Es werden keine zusätzlichen personenbezogenen Daten verarbeitet, die über das ursprüngliche Interviewmaterial hinausgehen.

Hip osteoarthritis is one of the most common joint diseases worldwide. When pain becomes chronic and everyday activities such as walking, climbing stairs, or sleeping are increasingly restricted, a hip replacement can help patients regain mobility and independence.

In this PRIMO MEDICO Expert Talk podcast episode, Prof. Dr Guido Saxler, Director of the Department of Orthopaedics and Trauma Surgery at Rheinland Klinikum Dormagen, explains when hip replacement surgery becomes necessary and how modern minimally invasive techniques enable faster recovery from joint pain and excellent long-term outcomes.

Listen now to learn how advances in hip replacement surgery are helping patients achieve lasting pain relief and a better quality of life!

This podcast episode in English was produced using AI-powered translation and dubbing technology (ElevenLabs Dubbing) based on the original recording. The content corresponds to the original interview. The AI voice has been used with the consent of the interviewee. No additional personal data has been processed.

When pancreatic cancer is diagnosed, the prognosis is usually poor. This is primarily because pancreatic tumors are often detected at a late stage. Under more favorable conditions, however, modern surgical techniques offer patients a good chance of gaining valuable time and perhaps even achieving a cure through surgery.

When is surgery an option for pancreatic cancer? What does pancreatic surgery involve? What is life like after oncologic surgery?

Prof. Dr. med. Alexis Ulrich is a specialist in oncological surgery and Head Physician of the Department of General and Visceral Surgery at the Lukas Hospital of the Rheinland Klinikum Neuss. On the PRIMO MEDICO Expert Talk podcast, he sheds light on how pancreatic tumors are diagnosed – why early detection matters – and what opportunities oncological pancreatic surgery offers today.

Please note: This podcast is intended for general information and cannot replace an individual medical consultation, diagnosis or treatment recommendation.

Topics include:

This episode in English was produced using AI-powered translation and dubbing technology (ElevenLabs Dubbing) based on the original recording. The content corresponds to the original interview. The AI voice has been used with the consent of the interviewee. No additional personal data has been processed.

Persistent shoulder pain can significantly affect quality of life – especially when everyday movements become difficult and sleep is disrupted by pain at night. In many cases, worn joint surfaces and damaged tendons lead to a loss of shoulder function and increasing discomfort. If left untreated, there is a risk of developing instability-related osteoarthritis and damage to the rotator cuff. In 90% of cases, the causes of shoulder instabilities are dislocations.

In this podcast episode, shoulder expert Dr. Andreas Kiekenbeck, Medical Director and Chief Physician at ATOS MVZ Wiesbaden, is explaining when shoulder replacement becomes necessary and which type of prosthesis is best suited to each patient. “Our goal is for our patients to be able to resume their physical exercises and activities!”

Many patients suffer from shoulder tendon problems that disrupt the interaction between the joint surfaces and muscles, eventually leading to joint deterioration. According to shoulder specialist Dr. Kiekenbeck, shoulder replacement becomes an option when persistent pain – even at night – and restricted movement significantly limit a patient’s ability to manage everyday activities independently.

Which type of shoulder prosthesis is best suited to which patient? What are the advantages of a reverse shoulder prosthesis? And how quickly does shoulder pain subside after surgery? Listen and learn how modern shoulder replacement surgery can help patients regain mobility and quality of life!

Topics include:

This podcast episode in English was produced using AI-powered translation and dubbing technology (ElevenLabs Dubbing) based on the original recording. The content corresponds to the original interview. The AI voice has been used with the consent of the interviewee. No additional personal data has been processed.

Eine künstliche Hüfte bedeutet heutzutage nicht mehr automatisch einen langen Heilungsverlauf. Was ist eine besonders schonende Methode für einen Hüftgelenkersatz? Wie gelingt es nach einer Hüftoperation schneller wieder mobil zu werden? Welche Vorteile bietet der minimalinvasive, sogenannte ASI-Zugang gegenüber herkömmlichen Operationsmethoden? Und was steckt hinter dem modernen Rapid-Recovery-Konzept?

In dieser Folge des PRIMO MEDICO Fachärzte-Talks ist Dr. med. Ahmet Ercan zu Gast. Der Spezialist für Hüftchirurgie der ATOS Orthoparc Klinik Köln spricht über eine der modernsten Methoden des künstlichen Hüftgelenkersatzes, den ASI-Zugang, der eine besonders schonende Hüftoperationsmethode darstellt.

Dr. Ercan erklärt, warum beim ASI-Zugang Muskeln und wichtige Gewebestrukturen geschont werden, weshalb viele Patientinnen und Patienten bereits wenige Stunden nach der Operation wieder aufstehen können und wie ein interdisziplinäres Behandlungskonzept zu einer schnelleren Genesung beiträgt.

Verständlich erklärte Themen über Hüftoperationen:

Diese Podcast-Folge wurde mithilfe von KI-gestützten Audiotechnologien produziert. Die gesprochenen Inhalte werden vollständig durch KI-generierte Stimmen, basierend auf den interviewten Arzt wiedergegeben. Die medizinischen Inhalte wurden vor Veröffentlichung geprüft und freigegeben. Es werden keine zusätzlichen personenbezogenen Daten verarbeitet, die über das ursprüngliche Interviewmaterial hinausgehen.

Meningiomas are among the most common primary brain tumours and are usually benign. However, a diagnosis often raises many questions for patients and their families. This episode of PRIMO MEDICO’s Expert Physician Talk focuses on non-malignant tumours of the meninges, which – although innocent – can nevertheless have significant neurological effects depending on their location and size.

Prof. Dr. med. Makoto Nakamura is Head of the Neurosurgery Department at the Clinics of the City of Cologne – Merheim Hospital – as well as Professor at Witten/Herdecke University. He is explaining characterises of meningiomas, how they differ from other brain tumours, and how common these types of meningeal growths are. Possible genetic and hormonal factors, typical symptoms and warning signs are outlined by the renowned neurosurgeon in this podcast episode. Also included are further topics like aspects of prevention, diagnostic procedures as MRI, criteria for observation, surgery or radiotherapy, and modern neurosurgical techniques.

Professor Nakamura is also illustrating risks, prospects of success, aftercare plans, and supportive measures for patients, concluding with the provision of an overview of current developments in neurosurgery.

This podcast episode in English was produced using AI-powered translation and dubbing technology (ElevenLabs Dubbing) based on the original recording. The content corresponds to the original interview. The AI voice has been used with the consent of the interviewee. No additional personal data has been processed.

Das Ovarialkarzinom zählt zu den aggressivsten gynäkologischen Krebserkrankungen und wird häufig erst in einem fortgeschrittenen Stadium entdeckt, da frühe Symptome meist unspezifisch sind oder ganz fehlen. Umso wichtiger sind eine fundierte Aufklärung, moderne Diagnostik und individuell abgestimmte Therapiekonzepte.

In dieser Folge des PRIMO MEDICO Fachärzte-Talks spricht Prof. Dr. med. Tanja N. Fehm, Direktorin der Frauenklinik und Spezialistin für Gynäkologische Onkologie am Universitätsklinikum Düsseldorf, über die aktuellen Möglichkeiten in der Behandlung des Eierstockkrebses und erklärt, warum die Versorgung in einem spezialisierten Zentrum entscheidend für den Therapieerfolg sein kann.

Professor Fehm illustriert die Bedeutung genetischer Untersuchungen, insbesondere im Hinblick auf BRCA-Mutationen und andere erblich bedingte Risikofaktoren, und erklärt, warum diese Informationen heute einen wichtigen Einfluss auf die Wahl der Therapie haben. Die diversen Behandlungsmöglichkeiten sind Thema dieser Podcast-Episode.

Neben der operativen Tumorentfernung, die eine zentrale Rolle spielt, geht es um die Kombination mit Chemotherapie sowie den Einsatz zielgerichteter Medikamente wie PARP-Inhibitoren. Zudem werden aktuelle Entwicklungen in der personalisierten Onkologie sowie neue Therapieansätze vorgestellt, die die Prognose vieler Patientinnen in den vergangenen Jahren deutlich verbessert haben. Zudem gibt die Spezialistin für Frauenheilkunde Einblicke in die Nachsorge der Heilverfahren und erklärt, weshalb eine langfristige Begleitung inklusive der Versorgung möglicher Rückfälle ebenso wichtig sind wie die Ersttherapie. Dabei stehen nicht nur medizinische Aspekte im Mittelpunkt, sondern auch die Lebensqualität der Patientinnen und die enge Zusammenarbeit mit verschiedenen Fachdisziplinen.

Interview mit Moderatorin Viola Gräfenstein

The thyroid gland is shaped like a small butterfly and is located inside the neck just below the larynx. It acts as a kind of control center for energy, mood, and growth. If the endocrine gland becomes unbalanced, it can lead to various thyroid disorders.

In this episode of PRIMO MEDICO’s expert talk, Katharina von Schenk, Head Physician at the clinic for Endocrine Surgery of Lukaskrankenhaus in Neuss – Germany’s Rhineland, discusses graves’ disease, an autoimmune disorder leading to an overactive thyroid called Graves' hyperthyroidism.

The recorded conversation about autoimmune hyperthyroidism covers typical triggers and symptoms as well as key diagnostic steps – including laboratory tests, ultrasound and scintigraphy – in addition to various treatment options such as medication, radioiodine therapy, and surgery. The expert in endocrine surgery explains when surgical procedures become necessary, what risks treatments entail and what aftercare involves. The dialogue also covers how comorbidities are considered and when those affected should seek early treatment options at a specialist clinic.

This podcast episode in English was produced using AI-powered translation and dubbing technology (ElevenLabs Dubbing) based on the original recording. The content corresponds to the original interview. The AI voice has been used with the consent of the interviewee. No additional personal data has been processed.

The prostate is a gland located directly below the bladder. With roughly the size of a 4 cm walnut, it surrounds the urethra and can be affected by cancer, especially in older men.

In this PRIMO MEDICO expert podcast episode, Prof. Dr Daniel M. Aebersold explains his radiation therapy procedures for the treatment of prostate cancer.

The decision to apply radiation therapy rather than surgery (or intraoperative radiotherapy or radiosurgery), depends on various factors. The first consideration is whether the tumour should be treated at all or if monitoring the cancer cells might be sufficient. This again depends on both, the patient’s general state of health as well as the estimated life expectancy. Moreover, the cancer’s current stage and the spectrum of potential side effects are taken into consideration.

The specialist in radiation oncology and radiotherapy Prof. Aebersold is head physician at the Department of Radiation Oncology at Inselspital – University Hospital Bern in Switzerland. He explains prostate radiation and facts regarding treatment planning, procedure steps involved and duration, prospects of recovery, side effects, chances of survival, and the preservation of sexual function.

Prof. Aebersold emphasizes that modern radiation therapies achieve excellent tumour control while minimizing side effects and offering many patients a highly effective, non-invasive treatment option with very promising long-term outcomes.

This podcast episode in English was produced using AI-powered translation and dubbing technology (ElevenLabs Dubbing) based on the original recording. The content corresponds to the original interview. The AI voice has been used with the consent of the interviewee. No additional personal data has been processed.